SGLT2 Inhibitors for Diabetes: No Link to Fractures in Older Adults
Use of sodium-glucose cotransporter-2 (SGLT2) inhibitors does not appear to raise the risk for fractures in older adults, new research […]
New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according […] The AMPLITUDE-O phase 3 trial showed that investigational drug efpeglenatide (Sanofi/Hanmi Pharmaceutical) — an exendin-based glucagon-like peptide-1 (GLP-1) receptor agonist […]diab
New biomarkers in the eyes could unlock the key to management of diabetic retinopathy
AMPLITUDE-O: Efpeglenatide Benefits in High-Risk Diabetes